Most Recent
A class action against Allergan over recalled breast implants has lost its bid to strike out the US drug company’s defence that there was no known causal link between its implants and a certain form of cancer at the time of supply.
Fiducian Investment Management has copped a $7.3 million penalty after admitting that it made misleading representations about the ESG credentials of an investment fund, despite senior execs being warned about its exposure to fossil fuels.
In ordering early registration for a class action against a Johnson & Johnson unit, which estimates its defence costs at over $22 million, a judge has said the "very expensive" process is appropriate.
A judge has granted Johnson & Johnson's bid for soft class closure in a class action over alleged ineffective cold medications, saying it would aid in settlement negotiations.
Two Deloitte reports commissioned by a Swiss law firm for Credit Suisse are protected by legal professional privilege despite access given to financial regulators investigating the collapse of supply chain financier Greensill.
The applicants in class actions over alleged engine defects in Hyundai and Kia vehicles can file amended cases, over the objections of the car makers, which claim the new pleadings are "worse" despite millions of dollars having been spent on discovery.
A judge has allowed a "painfully slow" competition class action against Sony over its PlayStation store practices to file an amended pleading, after expressing concerns the case was not properly resourced.
Credit Suisse is fighting a bid for access to Deloitte reports commissioned by a Swiss law firm and advice from Linklaters, in litigation against insurers over the collapse of supply chain finance company Greensill Capital.
A class action against Johnson & Johnson over alleged ineffective cold medicine has attacked the pharmaceutical company’s application for soft class closure, telling a court the process would produce useless data and only need to be repeated.
The lead shareholder in class actions against CBA has urged the High Court to take a "common sense" approach to loss causation in securities cases, as endorsed by the Full Federal Court in last month's ruling for Worley's investors.